TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Colorectal Cancer Market – By Modality
1.3.2 Europe Colorectal Cancer Market – By End User
1.3.3 Europe Colorectal Cancer Market – By Country
2. Europe Colorectal Cancer Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Colorectal Cancer– Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Expert Opinion
5. Europe Colorectal Cancer Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Colorectal Cancer
5.1.2 New Product Launches
5.1.3 Benefits Offered by Generic Drugs
5.2 Market Restraints
5.2.1 Pricing Pressure on Drug Manufacturers
5.3 Future Trends
5.3.1 Shift Toward Personalized Medicine
5.4 Impact Analysis
6. Europe Colorectal Cancer Market– Europe Analysis
6.1 Europe Colorectal Cancer Market Revenue Forecast and Analysis
7. Europe Colorectal Cancer Market Analysis – By Modality
7.1 Overview
7.2 Europe Colorectal Cancer Market Revenue Share, By Modality 2022 & 2028 (%)
7.3 Diagnosis Type
7.3.1 Overview
7.3.2 Diagnosis Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Immunohistochemistry
7.3.3.1 Overview
7.3.3.2 Immunohistochemistry: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Stool Test
7.3.4.1 Overview
7.3.4.2 Stool Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.3.5 Flexible Sigmoidoscopy
7.3.5.1 Overview
7.3.5.2 Flexible Sigmoidoscopy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.3.6 Colonoscopy
7.3.6.1 Overview
7.3.6.2 Colonoscopy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.3.7 CEA Test
7.3.7.1 Overview
7.3.7.2 CEA Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.3.8 Other Test
7.3.8.1 Overview
7.3.8.2 Other Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Therapy Type
7.4.1 Overview
7.4.2 Europe Therapy Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Chemotherapy
7.4.3.1 Overview
7.4.3.2 Chemotherapy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3.3 Alkylating Agent
7.4.3.3.1 Overview
7.4.3.3.2 Alkylating Agent: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3.4 Antimetabolites
7.4.3.4.1 Antimetabolites: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3.5 Others
7.4.3.5.1 Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4 Immunotherapy
7.4.4.1 Overview
7.4.4.2 Immunotherapy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4.3 Panitumumab
7.4.4.3.1 Overview
7.4.4.3.2 Panitumumab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4.4 Cetuximab
7.4.4.4.1 Overview
7.4.4.4.2 Cetuximab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4.5 Bevacizumab
7.4.4.5.1 Overview
7.4.4.5.2 Bevacizumab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4.6 Others
7.4.4.6.1 Overview
7.4.4.6.2 Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.5 Chemoprotectant
7.4.5.1 Overview
7.4.5.2 Chemoprotectant: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.6 Others
7.4.6.1 Overview
7.4.6.2 Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Imaging Type
7.5.1 Overview
7.5.2 Europe Imaging Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.5.3 Computed Tomography (CT)
7.5.3.1 Overview
7.5.3.2 Computed Tomography (CT) : Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.5.4 Magnetic Resonance Imaging (MRI)
7.5.4.1 Overview
7.5.4.2 Magnetic Resonance Imaging (MRI) : Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.5.5 Others
7.5.5.1 Overview
7.5.5.2 Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
8. Europe Colorectal Cancer Market Revenue and Forecast To 2028 – By End User
8.1 Overview
8.2 Europe Colorectal Cancer Market Revenue Share, By End User 2022 & 2028 (%)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Diagnostic and Research Laboratories
8.4.1 Overview
8.4.2 Diagnostic and Research Laboratories: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe Colorectal Cancer Market Revenue and Forecast to 2028 – Country Analysis
9.1 Overview
9.1.1 Europe: Colorectal Cancer Market, by Country, 2022 & 2028 (%)
9.1.1.1 Germany: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.1.1 Germany: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.1.2 Germany: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.1.1.1.2.1 Germany: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.1.1.1.2.2 Germany: Colorectal Cancer Market, by Therapy Type – 2019- 2028 (US$ Million)
9.1.1.1.2.2.1 Germany: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)
9.1.1.1.2.2.2 Germany: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
9.1.1.1.2.3 Germany: Colorectal Cancer Market, by Imaging Type – 2019–2028 (US$ Million)
9.1.1.1.3 Germany: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.1.1.2 France: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.2.1 France: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.2.2 France: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.1.1.2.2.1 France: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.1.1.2.2.2 France: Colorectal Cancer Market, by Therapy Type – 2019- 2028 (US$ Million)
9.1.1.2.2.2.1 France: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)
9.1.1.2.2.2.2 France: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
9.1.1.2.2.3 France: Colorectal Cancer Market, by Imaging Type – 2019–2028 (US$ Million)
9.1.1.2.3 France: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.1.1.3 UK: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.3.1 UK: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.3.2 UK: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.1.1.3.2.1 UK: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.1.1.3.2.2 UK: Colorectal Cancer Market, by Therapy Type – 2019- 2028 (US$ Million)
9.1.1.3.2.2.1 UK: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)
9.1.1.3.2.2.2 UK: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
9.1.1.3.2.3 UK: Colorectal Cancer Market, by Imaging Type – 2019–2028 (US$ Million)
9.1.1.3.3 UK: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.1.1.4 Italy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.4.1 Italy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.4.2 Italy: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.1.1.4.2.1 Italy: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.1.1.4.2.2 Italy: Colorectal Cancer Market, by Therapy Type – 2019- 2028 (US$ Million)
9.1.1.4.2.2.1 Italy: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)
9.1.1.4.2.2.2 Italy: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
9.1.1.4.2.3 Italy: Colorectal Cancer Market, by Imaging Type – 2019–2028 (US$ Million)
9.1.1.4.3 Italy: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.1.1.5 Spain: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.5.1 Spain: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.5.2 Spain: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.1.1.5.2.1 Spain: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.1.1.5.2.2 Spain: Colorectal Cancer Market, by Therapy Type – 2019- 2028 (US$ Million)
9.1.1.5.2.2.1 Spain: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)
9.1.1.5.2.2.2 Spain: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
9.1.1.5.2.2 Spain: Colorectal Cancer Market, by Imaging Type – 2019–2028 (US$ Million)
9.1.1.5.3 Spain: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.1.1.6 Rest of Europe: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.6.1 Rest of Europe: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.6.2 Rest of Europe: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.1.1.6.2.1 Rest of Europe: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.1.1.6.2.2 Rest of Europe: Colorectal Cancer Market, by Therapy Type – 2019- 2028 (US$ Million)
9.1.1.6.2.2.1 Rest of Europe: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)
9.1.1.6.2.2.2 Rest of Europe: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
9.1.1.6.2.3 Rest of Europe: Colorectal Cancer Market, by Imaging Type – 2019–2028 (US$ Million)
9.1.1.6.3 Rest of Europe: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
10. Global Colorectal Cancer Market – Industry Landscape
10.1 Overview
10.2 Growth Strategies In The Colorectal Cancer Market, 2022-2028
10.3 Organic Developments
10.3.1 Overview
10.3.2 Organic Growth Strategies In The Colorectal Cancer Market, 2022-2028
10.4 Inorganic Developments
10.4.1 Overview
10.4.2 Inorganic Growth Strategies In The Colorectal Cancer Market, 2022-2028
11. Company Profiles
11.1 Epigenomics AG
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Novigenix SA
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Abbott
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Amgen Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 F. HOFFMANN-LA ROCHE LTD.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Bruker Corporation
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Quest Diagnostics Incorporated
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 EDP Biotech Corporation
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Volitionrx Limited
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
LIST OF TABLES.
Table 1. Germany: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
Table 2. Germany: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 3. Germany: Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 4. Germany: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 5. Germany: Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 6. Germany: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 7. Germany: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
Table 8. France: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
Table 9. France: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 10. France: Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 11. France: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 12. France: Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 13. France: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. France: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
Table 15. UK: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
Table 16. UK: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 17. UK: Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 18. UK: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 19. UK: Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 20. UK: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 21. UK: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
Table 22. Italy: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
Table 23. Italy: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 24. Italy: Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 25. Italy: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 26. Italy: Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 27. Italy: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 28. Italy: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
Table 29. Spain: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
Table 30. Spain: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 31. Spain: Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 32. Spain: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 33. Spain: Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 34. Spain: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 35. Spain: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
Table 36. Rest of Europe: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
Table 37. Rest of Europe: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 38. Rest of Europe: Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 39. Rest of Europe: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 40. Rest of Europe: Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 41. Rest of Europe: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 42. Rest of Europe: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
Table 43. Recent Organic Growth Strategies In The Colorectal Cancer Market
Table 44. Recent Inorganic Growth Strategies In The Colorectal Cancer Market
Table 45. Glossary of Terms, Europe Colorectal Cancer Market